Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Mezzion reports promising topline data from phase III FUEL study of udenafil

July 31, 2019

Selective CaMKII inhibition by gene therapy suppresses arrhythmias in CPVT models

July 30, 2019

PARAGON-HF study of sacubitril/valsartan misses statistical significance on primary endpoint

July 29, 2019

King Saud University discovers new calcium channel blockers

July 25, 2019

Hypertrophic cardiomyopathy model shows potential of phosphomimetic-RLC gene therapy

July 22, 2019

Ambrx announces initiation of phase I study of a long-acting relaxin

July 17, 2019

New hamster model of carotid artery atherothrombotic occlusion developed

July 12, 2019

SP-8356, a CD147 inhibitor, is a potential compound for treating atherosclerosis

July 5, 2019

New phase IIa ELEVATE 1 study investigates RVT-1201 for pulmonary arterial hypertension

July 5, 2019

Low-dose mercury causes heart failure in mice

July 3, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...